Introgen Therapeutics, Inc.
Recent developments from Introgen Therapeutics, Inc., highlighted
Published in Healthcare Mergers, Acquisitions and Ventures Week, June 23rd, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Introgen Therapeutics, Inc.
Report 1: Introgen Therapeutics, Inc. (NASDAQ:INGN) reported updated ADVEXIN(R) biomarker data over the weekend in Los Angeles, California at the Annual Meeting of the American Association for Cancer Research.
Abnormality of the p53 tumor suppressor is one of the most common and fundamental molecular defects in cancer. ADVEXIN's mechanism of action is targeted to restoring p53 tumor suppressor function and the detection of abnormal p53...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- 1-800 CONTACTS, INC.
1-800 CONTACTS to Be Acquired by Fenway Partners - A.D.A.M., Inc.
A.D.A.M. and Aon Corporation Launch MyAonAssist - AARP New York
Long Island Seniors Rally for Rx Affordable Prescription Drugs and Cell Phone Protections - Abbott
Abbott Signs Agreement With Novation for Diagnostic Equipment and Tests - Abbott
First Bright Space Developed to Give Children Living With Substance Abuse a Dedicated Play and Learning Environment - AcademyHealth
AcademyHealth Honors Leading Health Services Researchers - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
